Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study.
Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study. BMC Pulm Med. 2022 Jan 06; 22(1):26.